Education
About Us
Working with TipRanks
Follow Us
China Regenerative Medicine International Limited (HK:8158)
:8158
RESEARCH TOOLSreports
8158 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.09 - HK$1.27
Previous CloseN/A
Volume500.00
Average Volume (3M)157.46K
Market Cap
HK$118.66M
Enterprise ValueHK$485.59M
Total Cash (Recent Filing)HK$57.45M
Total Debt (Recent Filing)HK$53.69M
Price to Earnings (P/E)6.7
Beta0.37
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding304,252,470
10 Day Avg. Volume282,330
30 Day Avg. Volume157,461
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.97
Price to Sales (P/S)0.00
P/FCF Ratio-6.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8158 FAQ
What was China Regenerative Medicine International Limited’s price range in the past 12 months?
China Regenerative Medicine International Limited lowest stock price was HK$0.09 and its highest was HK$1.27 in the past 12 months.
What is China Regenerative Medicine International Limited’s market cap?
China Regenerative Medicine International Limited’s market cap is HK$118.66M.
When is China Regenerative Medicine International Limited’s upcoming earnings report date?
China Regenerative Medicine International Limited’s upcoming earnings report date is May 15, 2025 which is 34 days ago.
How were China Regenerative Medicine International Limited’s earnings last quarter?
China Regenerative Medicine International Limited released its earnings results on Mar 28, 2025. The company reported HK$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.003.
Is China Regenerative Medicine International Limited overvalued?
According to Wall Street analysts China Regenerative Medicine International Limited’s price is currently Overvalued.
Does China Regenerative Medicine International Limited pay dividends?
China Regenerative Medicine International Limited does not currently pay dividends.
What is China Regenerative Medicine International Limited’s EPS estimate?
China Regenerative Medicine International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Regenerative Medicine International Limited have?
China Regenerative Medicine International Limited has 304,252,470 shares outstanding.
What happened to China Regenerative Medicine International Limited’s price movement after its last earnings report?
China Regenerative Medicine International Limited reported an EPS of HK$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of China Regenerative Medicine International Limited?
Currently, no hedge funds are holding shares in HK:8158
China Regenerative Medicine International Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
108.55%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-48.74%
Trailing 12-Months
Company Description
China Regenerative Medicine International Limited
China Regenerative Medicine International Limited, an investment holding company, produces and sells healthcare products and services. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Shandong Weigao Group Medical Polymer Co
―
Livzon Pharmaceutical Group
―
China Medical System Holdings
―